Clinical Trial

Development of a FibroScan Liver Examination Using a Single Probe

Study acronym: M149
Recruiting
View on ClinicalTrials.gov →
Summary
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
Protocol Amendment History 3 changes
notable Enrollment increased: 309 -> 389 participants 2026-08-06
notable Primary completion pushed: 2026-11-30 -> 2026-12-31 2026-08-06
minor Completion pushed: 2026-12-31 -> 2027-05-31 2026-08-06
Trial Details
NCT Number NCT07400289
Lead Sponsor Echosens
Collaborators: Novotech CRO
Conditions Liver Diseases
Enrollment 389 participants
Start Date 2025-11-14
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-05